
You have the great idea, the market validation is underway and you’ve shaken down all your rich relatives for seed funding. Your business plan forecasts a cash burn of $250k for the next 12 months and your back account is starting to look shaky. What can you do to keep things on track?
Our panelists will explore the options available to early-stage companies to leverage funding through government grants and support programs, such as AusIndustry’s Commercial Ready. We will also look at the trends in pre-seed venture investing and examine the growth of alternative sources of capital, including the state of angel activity in Australia.
This session is proudly presented in conjunction with AusIndustry and there will representatives on hand from State and Commonwealth agencies to provide further information on the programs covered by the panel.
Tim Wawn, CEO, Applimex Systems
Tim Wawn is CEO of Applimex Systems, a privately owned biotech company commercialising enzymes for industrial and therapeutic applications. He possesses extensive experience in commercialising new technologies in the biotechnology sector, both within Australia and Internationally. Tim is a chartered accountant and holds a Master of Business Administration from the AGSM.


